View in EDS HTML Full Text PDF Full Text

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].

Saved in:
Bibliographic Details
Title: Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
Authors: Poh XY; National Centre for Infectious Diseases, Singapore, Singapore., Lee IR; National Centre for Infectious Diseases, Singapore, Singapore., Lim C; National Centre for Infectious Diseases, Singapore, Singapore., Teo J; National Centre for Infectious Diseases, Singapore, Singapore., Rao S; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore., Chia PY; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Ong SWX; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore., Lee TH; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore., Lin RJH; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore., Ng LFP; A*STAR Infectious Diseases Lab, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ren EC; Singapore Immunology Network, A*STAR, Singapore, Singapore., Lin RTP; National Public Health Laboratory, Singapore, Singapore., Wang LF; Duke-NUS Medical School, Singapore, Singapore., Renia L; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; A*STAR Infectious Diseases Lab, Singapore, Singapore., Lye DC; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Young BE; National Centre for Infectious Diseases, Singapore, Singapore. barnaby_young@ncid.sg.; Tan Tock Seng Hospital, Singapore, Singapore. barnaby_young@ncid.sg.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. barnaby_young@ncid.sg.
Source: Trials [Trials] 2022 Jun 16; Vol. 23 (1), pp. 498. Date of Electronic Publication: 2022 Jun 16.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35710572
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Poh+XY%22">Poh XY</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+IR%22">Lee IR</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+C%22">Lim C</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Teo+J%22">Teo J</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Rao+S%22">Rao S</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chia+PY%22">Chia PY</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ong+SWX%22">Ong SWX</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+TH%22">Lee TH</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lin+RJH%22">Lin RJH</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ng+LFP%22">Ng LFP</searchLink>; A*STAR Infectious Diseases Lab, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ren+EC%22">Ren EC</searchLink>; Singapore Immunology Network, A*STAR, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lin+RTP%22">Lin RTP</searchLink>; National Public Health Laboratory, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Wang+LF%22">Wang LF</searchLink>; Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Renia+L%22">Renia L</searchLink>; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; A*STAR Infectious Diseases Lab, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lye+DC%22">Lye DC</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore.; Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Young+BE%22">Young BE</searchLink>; National Centre for Infectious Diseases, Singapore, Singapore. barnaby_young@ncid.sg.; Tan Tock Seng Hospital, Singapore, Singapore. barnaby_young@ncid.sg.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. barnaby_young@ncid.sg.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101263253%22">Trials</searchLink> [Trials] 2022 Jun 16; Vol. 23 (1), pp. 498. <i>Date of Electronic Publication: </i>2022 Jun 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial Protocol; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101263253 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1745-6215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217456215%22">17456215 </searchLink><i>NLM ISO Abbreviation: </i>Trials <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35710572
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13063-022-06345-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 498
    Titles:
      – TitleFull: Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Poh XY
      – PersonEntity:
          Name:
            NameFull: Lee IR
      – PersonEntity:
          Name:
            NameFull: Lim C
      – PersonEntity:
          Name:
            NameFull: Teo J
      – PersonEntity:
          Name:
            NameFull: Rao S
      – PersonEntity:
          Name:
            NameFull: Chia PY
      – PersonEntity:
          Name:
            NameFull: Ong SWX
      – PersonEntity:
          Name:
            NameFull: Lee TH
      – PersonEntity:
          Name:
            NameFull: Lin RJH
      – PersonEntity:
          Name:
            NameFull: Ng LFP
      – PersonEntity:
          Name:
            NameFull: Ren EC
      – PersonEntity:
          Name:
            NameFull: Lin RTP
      – PersonEntity:
          Name:
            NameFull: Wang LF
      – PersonEntity:
          Name:
            NameFull: Renia L
      – PersonEntity:
          Name:
            NameFull: Lye DC
      – PersonEntity:
          Name:
            NameFull: Young BE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 06
              Text: 2022 Jun 16
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1745-6215
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Trials
              Type: main
ResultId 1